N stage (HR = 1.520, P < 0.001) and T stage (HR = 1.432, P = 0.001) were identified as the independent predictors of the OS of patients with GC rather than ZNF545 promoter methylation, as revealed by the multivariate survival analysis (Table 2). Here, ZFP82 is linked to gastric cancer.